Cell Chemical Biology

Papers
(The median citation count of Cell Chemical Biology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1143
A versatile residue numbering scheme for Nav and Cav channels138
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance130
A covalent inhibitor targeting Cys16 on RhoA in colorectal cancer109
Next steps for targeted protein degradation107
Advances in spatial proteomics: Mapping proteome architecture from protein complexes to subcellular localizations98
FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication95
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation91
Voices: Challenges and opportunities in regulating the immune system90
Meet the Authors: Christopher R. Mansfield and Emily R. Derbyshire88
RENBP inhibition amplifies metabolic glycan labeling efficiency of antigen-presenting cells in vitro and in vivo88
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas87
An interactive resource mapping the proteome and reactive cysteine landscape across the NCI-60 reveals cell and tissue-specific profiles86
Therapeutic potential of inhibiting the PI3Kγ complex for leukemia85
2′-OH as a universal handle for studying intracellular RNAs82
A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection79
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development78
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine77
CBLs downregulation foretells T cell ubiquitination leading to autoimmunity74
Meet the Authors: Harkamal S. Jhajj and Peter M. Tessier68
Catalytic spike antibodies: A new paradigm in neutralization67
Valence and avidity determine the agonistic activity of anti-TNFR2 nanobody fusion proteins66
Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration65
Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells61
Meet the Cell Chemical Biology author and newest advisory board member: Marcus Conrad60
A complex puzzle: Regulation of SLFN12 RNase activity by phosphorylation60
N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis57
Engineered pistol ribozymes selectively target KRAS G12V with enhanced efficacy by capping modification57
Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy57
Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions54
Targeting the endocannabinoid-eicosanoid axis to treat pain: Promise and pitfalls54
Selective degradation of TBK1 uncovers mechanistic insights into blocking ccRCC progression54
Real-time non-invasive fluorescence imaging of gut commensal bacteria to detect dynamic changes in the microbiome of live mice54
Beyond antibiotic resistance: The whiB7 transcription factor coordinates an adaptive response to alanine starvation in mycobacteria53
A potent NLRP3 inhibitor effective against both MCC950-sensitive and -resistant inflammation51
Pharmacological management of disease by overcoming structural adversity50
A double whammy for KEAP150
The art of designed coiled-coils for the regulation of mammalian cells48
De novo protein assembly enables drug-controlled cellular functions47
Discovery of MARK2 as a physiological kinase for PER2 in the mammalian clock47
Visualizing Staphylococcus aureus pathogenic membrane modification within the host infection environment by multimodal imaging mass spectrometry46
BLOC-1 and BORC: Complex regulators of endolysosomal dynamics43
PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication42
Metabolic tug-of-war: Microbial metabolism shapes colonization resistance against enteric pathogens42
Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges42
Structural basis for NONO-specific modification by the α-chloroacetamide compound (R)-SKBG-141
A new chink in cancer’s armor: Unleashing cell death by selective PP5 inhibition40
Enabling inclusion and looking ahead39
SynPull: An advanced method for studying neurodegeneration-related aggregates in synaptosomes using super-resolution microscopy38
Two sides of a co(i)ndensate38
Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases38
Arabinose- and xylose-modified analogs of 2′,3′-cGAMP act as STING agonists38
Two genomes, one destiny: Mitophagy at the crossroads of inheritance and disease37
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome37
Deciphering the opioid code37
Meet the authors: Aayushi Uberoi and Elizabeth A. Grice37
Linked-domain inhibitors designed to block UBE2D induce the unfolded protein response37
Emerging biochemical, microbial and immunological evidence in the search for why HLA-B∗27 confers risk for spondyloarthritis36
Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation35
Covalent inhibition of ACSL4 alleviates ferroptosis-induced acute liver injury35
Natural products chlorotonils exert a complex antibacterial mechanism and address multiple targets35
Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors35
Behavioral control through the direct, focal silencing of neuronal activity34
HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation34
Sorting out extracellular proteins: SORTACs harness sortilin for targeted protein degradation33
The membrane strikes back: A mechanical force awakens antiviral defense33
Humanized zebrafish as a tractable tool for in vivo evaluation of pro-myelinating drugs33
IAP-based biodegraders can convert necroptosis to apoptosis and eliminate cancer driving protein complexes33
Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria33
Screening in serum-derived medium reveals differential response to compounds targeting metabolism32
S-Nitrosylation-mediated dysfunction of TCA cycle enzymes in synucleinopathy studied in postmortem human brains and hiPSC-derived neurons32
Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite32
Therapeutic induction of ferroptosis in tumors using PD-L1 targeting antibody nanogel conjugates32
Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections32
Capsaicin ameliorates inflammation in a TRPV1-independent mechanism by inhibiting PKM2-LDHA-mediated Warburg effect in sepsis31
PCNA degradation exhibits superior pharmacological effects over stoichiometric inhibition31
Boosting glycolysis to combat fragile bone in type 1 diabetes31
Induced proximity in biology and therapeutics31
Feel the breeze: Opening the therapeutic window with RIPTACs and induced proximity31
Structural and mechanistic analysis of covalent ligands targeting the RNA-binding protein NONO31
Mo’ m1A, mo’ problems31
Insights into lysophosphatidylserine recognition and Gα12/13-coupling specificity of P2Y1030
Selective killing of the human gastric pathogen Helicobacter pylori by mitochondrial respiratory complex I inhibitors30
Meet the authors: Mitchel L. Tepe and Huiqing Zhou30
Protomer selectivity of type II RAF inhibitors within the RAS/RAF complex30
D-aring to explore: New approaches to gasdermin D targeting30
Multiple PDE3A modulators act as molecular glues promoting PDE3A-SLFN12 interaction and induce SLFN12 dephosphorylation and cell death29
In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin29
Structural basis of CD97 activation and G-protein coupling28
Small molecule targeting of transcription-replication conflict for selective chemotherapy28
Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators28
Plant synthetic genomics: Big lessons from the little yeast28
Redox proteomics combined with proximity labeling enables monitoring of localized cysteine oxidation in cells28
Chemoproteomic profiling of substrate specificity in gut microbiota-associated bile salt hydrolases27
Discovery of a PROTAC degrader for METTL3-METTL14 complex27
Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate27
Decoding E1-E2 specificity: How UBA6 prioritizes BIRC6 for ubiquitin conjugation27
Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity27
Mechanisms and functions of lysosomal lipid homeostasis27
Epigenetic fluidity meets phenotypic malleability in intestinal epithelial cells27
The physiological and pathological roles of RNA modifications in T cells27
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers27
RNATACs: Multispecific small molecules targeting RNA by induced proximity27
Discovery and biosynthesis of non-canonical C16-terpenoids from Pseudomonas26
How to kill an ERKsome target: PROTACs deliver the deathblow26
Transcriptional restart: A new role for PARylation in overcoming DNA damage26
Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis25
An N terminomics toolbox combining 2-pyridinecarboxaldehyde probes and click chemistry for profiling protease specificity25
Targeting selective E3 ligase for healing cardiac fibrosis25
Lactylation of mTOR enhances autophagy in skeletal muscle during exercise25
Inhibitors of the ATPase p97/VCP: From basic research to clinical applications25
Targeting VPS41 induces methuosis and inhibits autophagy in cancer cells25
A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease25
De novo design of Ras isoform selective binders25
Membrane lipids regulate the STING pathway and type I interferon responses25
PARP trapping is governed by the PARP inhibitor dissociation rate constant25
Transcending cell death – The diverse roles of necroptosis signal adaptors in pathogen infection24
Voices: Challenges and opportunities for bioorthogonal chemistry24
The chemistry of electrical signaling in sodium channels from bacteria and beyond24
CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors24
Photo-proximity labeling in live primary neurons identifies an AMPA-receptor signal transducer in homeostatic synaptic plasticity24
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling24
Biogenesis and roles of tRNA queuosine modification and its glycosylated derivatives in human health and diseases23
Tools to investigate the cell surface: Proximity as a central concept in glycoRNA biology23
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders23
Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input23
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells23
Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor23
Host-like conditions validate nutrient transport as an antimalarial drug target22
Bortezomib inhibits ZIKV/DENV by interfering with viral polyprotein cleavage via the ERAD pathway22
The liquid lectin array detects compositional glycocalyx differences using multivalent DNA-encoded lectins on phage22
Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation22
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia22
MICU1 controls the sensitivity of the mitochondrial Ca2+ uniporter to activators and inhibitors22
Quinoline-based compounds can inhibit diverse enzymes that act on DNA21
Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp12021
The dark side of circular RNA, a new driver of genome instability21
Monitoring autophagic flux in vivo revealed its physiological response and significance of heterogeneity in pancreatic beta cells21
Development of D2HG biosensors inspired by the molecular mechanism of D2HG regulation of DhdR21
A small molecule PTER-selective inhibitor reduces food intake and body weight21
Immunity in motion: The role of mechanics in macrophage biology21
Phosphorylation barcodes direct biased chemokine signaling at CXCR320
Phytate enhances gut Parasutterella colonization to alleviate radiation injury20
Small-molecule allosteric inhibitors of GPX420
CryoSeek identification of glycofibrils with diverse compositions and structural assemblies20
Identification of an STING inhibitor targeting the allosteric transmembrane domains20
Clionamines stimulate autophagy, inhibit Mycobacterium tuberculosis survival in macrophages, and target Pik119
Meet the authors: Cydney N. Johnson, Shyra Wilde, Elaine Tuomanen, and Jason W. Rosch19
Visualization of the dynamic interaction between nucleosomal histone H3K9 tri-methylation and HP1α chromodomain in living cells19
A “light” touch on PI3K to interrogate cancer drug resistance19
METTL3: Melting the tumor microenvironment for improved immunotherapy19
The culinary chemist: Out of the lab and into the tent19
Ligand discovery by activity-based protein profiling19
One-pot trimodal mapping of unmethylated, hydroxymethylated, and open chromatin sites unveils distinctive 5hmC roles at dynamic chromatin loci19
Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors19
Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapy19
Peptide passports: Programmable import fuels novel protein building blocks19
New twists in anti-malarial drug resistance19
Beyond a degrader: VHL reprograms hypoxic metabolism19
Targeted degradation of CDK9 potently disrupts the MYC-regulated network18
A sterol analog inhibits hedgehog pathway by blocking cholesterylation of smoothened18
Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells18
One-carbon unit supplementation fuels purine synthesis in tumor-infiltrating T cells and augments checkpoint blockade18
Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling18
In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy18
Assessing the suitability of deubiquitylases as substrates for targeted protein degradation18
Robust antitumor treatment driven by lock-and-key biorecognition of dynamic cyclic diselenide-guided chiral prodrug self-assembly18
Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancers18
Meet the authors: Katerina Jones, Camila Bernardo de Brito, and Mariana Xavier Byndloss18
Strategies of bacterial detection by inflammasomes18
CBX4 acetoacetylation as an inhibitory mechanism of HIF-1α activity18
Sharks give a handle to potent anti-tumor multiparatopic antibodies inducing membrane depletion of PD-L118
STX-bpc: “Brightening” the path to neuronal inhibition18
Activation primes GPCRs for versatile coupling18
A method for the detection and enrichment of endogenous cereblon substrates17
The cyclimids: Degron-inspired cereblon binders for targeted protein degradation17
Intracellular cyclization-coupled peptide library screening yields potent transcription factor antagonists17
Discovery of dual-active ethionamide boosters inhibiting the Mycobacterium tuberculosis ESX-1 secretion system17
Target protein localization and its impact on PROTAC-mediated degradation17
Pharmacologic activation of a compensatory integrated stress response kinase promotes mitochondrial remodeling in PERK-deficient cells17
Small-molecule inhibitors of ferrochelatase are antiangiogenic agents17
Cytoplasmic tail diversity determines the effector bias of the adhesion GPCR ADGRL217
A proximity labeling-based orthogonal trap strategy identifies HDAC8 promotes cell motility by modulating cortactin acetylation17
Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response17
Ternary complex dissociation kinetics contribute to mutant-selective EGFR degradation17
Insights into biofilm architecture and maturation enable improved clinical strategies for exopolysaccharide-targeting therapeutics17
Recognition of the tRNA structure: Everything everywhere but not all at once16
Acylation probing of “generic” RNA libraries reveals critical influence of loop constraints on reactivity16
Ligand-induced assembly of antibody variable fragments for the chemical regulation of biological processes16
Causes, functions, and therapeutic possibilities of RNA secondary structure ensembles and alternative states16
Platelets accelerate lipid peroxidation and induce pathogenic neutrophil extracellular trap release16
Capturing the conversion of the pathogenic alpha-1-antitrypsin fold by ATF6 enhanced proteostasis16
Repurposing AS1411 for constructing ANM-PROTACs16
Chemical approaches to unraveling the biology of mycobacteria16
Degrading TBK1 to disarm VHL-deficient renal cancer15
Hydroxyproline metabolism enhances IFN-γ-induced PD-L1 expression and inhibits autophagic flux15
Identification of an endoplasmic reticulum proteostasis modulator that enhances insulin production in pancreatic β cells15
Spatiotemporally resolved GPCR interactome uncovers unique mediators of receptor agonism15
Reshaping the progranulin/sortilin interaction for targeted degradation of extracellular proteins15
Metabolic modulation of mitochondrial mass during CD4+ T cell activation15
Mechanosensation promotes broad-spectrum antiviral defense through membrane remodeling15
A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis14
The hydrophobicity of the CARD8 N-terminus tunes inflammasome activation14
Sensing within: Mitochondrial inside-out signal transduction14
Context-dependent regulation of ferroptosis sensitivity14
Specificity profiling of deubiquitylases against endogenously generated ubiquitin-protein conjugates14
Genetically encoded tool for manipulation of ΔΨm identifies its role as the driver of ISR induced by ATP synthase dysfunction14
Discovery of compounds that reactivate p53 mutants in vitro and in vivo14
Chemical genomics reveals targetable programs of human cancers rooted in pluripotency14
Degrading the signal amplifier: ITK as a target for targeted protein degradation14
High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface14
Regulation of bacterial gene expression by non-coding RNA: It is all about time!14
CysDB: a human cysteine database based on experimental quantitative chemoproteomics14
Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics14
The HEAT repeat protein MROH7 regulates the inflammatory macrophage response via LBP acetylation13
Genetically encoded manipulation of ATP/ADP ratio in human cells uncovers proteomic and physiological signatures of energy stress13
Endogenous anti-tumorigenic nitro-fatty acids inhibit the ubiquitin-proteasome system by directly targeting the 26S proteasome13
RPL22 links ribosome biogenesis, RNA splicing, and sensitivity to RNA polymerase I inhibition13
Targeting type I DED interactions at the DED filament serves as a sensitive switch for cell fate decisions13
Site-resolved assessment of targeted protein degradation13
Modifying the antiviral innate immune response by selective writing, erasing, and reading of m6A on viral and cellular RNA13
Engineering acyclovir-induced RNA nanodevices for reversible and tunable control of aptamer function13
Meet the authors: Xueqin Jin, Jian Huang, Huan Wang, Kan Wang, and Nieng Yan13
A sticky situation for targeted cancer therapy13
A base editor facilitates simultaneous purine and pyrimidine substitutions for ex vivo and in vivo mutagenesis screens13
Generation of glycan-specific nanobodies13
Genetically incorporated crosslinkers identify regulators of membrane protein PD-L1 in mammalian cells13
When CDK4/6i meets GPX4i: Stop dividing to die iron hard13
Raf protomers: Drug binding preferences in living cells13
Integration of metabolism and regulation reveals rapid adaptability to growth on non-native substrates12
Localization matters in targeted protein degradation12
Advances in degradomics technologies to assess proteolytic cleavage events12
Structural insights into inhibition mechanism of the helicase-primase complex from human herpesvirus 112
Anaerobic purinolytic enzymes enable dietary purine clearance by engineered gut bacteria12
The next Nobel Prize in chemistry or in physiology or medicine12
Genome- and metabolome-guided discovery of marine BamA inhibitors revealed a dedicated darobactin halogenase12
Targeting biomolecular condensates: The rise of engineered chaperones12
Cell-selective bioorthogonal labeling12
Inhibiting cancer metastasis with water-solubilized membrane receptor CXCR4QTY-Fc as a molecular trap12
Pantothenate kinase is an effective target for antifungal therapy12
Engineering electrogenetic interfaces for mammalian cell control12
Disruption to the gut microbiome by non-antibiotics is linked to infection risk12
Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules12
Chemical proteomics to study metabolism, a reductionist approach applied at the systems level12
Fluorogenic CRISPR for DNA imaging in live mammalian cells12
Engineering affinity-matured variants of an anti-polysialic acid monoclonal antibody with superior cytotoxicity-mediating potency12
Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessus12
Investigating the NRAS 5′ UTR as a target for small molecules12
Global profiling identifies a stress-responsive tyrosine site on EDC3 regulating biomolecular condensate formation11
Genetic retargeting of E3 ligases to enhance CAR T cell therapy11
0.16441988945007